SCHEMBL10041706

SCHEMBL10041706

O=S(=O)(Oc1ccc2cc(-c3ccc4ccccc4c3)ccc2c1)C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.54
CA1 P00915 4/20 0.54
CA9 Q16790 3/20 0.54
PPARG P37231 1/20 0.50
TDP1 Q9NUW8 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD11B1 P28845 1/20 0.43
GSTP1 P09211 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
ACMSD Q8TDX5 1/20 0.41
ALOX5 P09917 1/20 0.41
PTPN7 P35236 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14506126 1.00 CA2 (0.54) CA2CA1CA9PPARGTDP1
SCHEMBL11977690 0.98 CA2 (0.53) CA2CA1CA9PPARGTDP1
SCHEMBL14506139 0.93 CA2 (0.47) CA2CA1CA9PPARGTDP1
SCHEMBL31538684 0.93 CA2 (0.47) CA2CA1CA9PPARGTDP1
SCHEMBL25040047 0.93 CA2 (0.47) CA2CA1CA9PPARGTDP1
SCHEMBL29839512 0.93 CA1 (0.61) CA2CA1CA9PPARGTDP1
SCHEMBL1713420 0.93 CA1 (0.61) CA2CA1CA9PPARGTDP1
SCHEMBL14506101 0.93 HSD11B1 (0.47) CA2CA1CA9PPARGHSD11B1
SCHEMBL11978647 0.91 CA2 (0.45) CA2CA1CA9PPARGTDP1
SCHEMBL12107241 0.90 CA1 (0.47) CA2CA1CA9PPARGTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024526-B2 Fused polycyclic aromatic compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2024-07-02 US disclosed
US-12024526-B2 Fused polycyclic aromatic compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2024-07-02 US disclosed
US-20230047095-A1 Fused Polycyclic Aromatic Compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2023-02-16 US disclosed
US-20170317295-A1 NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-11-02 US disclosed
US-20170317295-A1 NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-11-02 US disclosed
EP-3214073-A2 NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME Heesung Material Ltd. (KR) 2017-09-06 EP disclosed
EP-2570412-B1 Novel nitrogen-containing heterocyclic compound and organic electronic device using the same LG CHEMICAL LTD (KR) 2017-01-04 EP disclosed
US-9331296-B2 Organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2016-05-03 US disclosed
US-9155160-B2 Method of manufacturing organic electroluminescence display device and electronic equipment including organic electroluminescence display device manufactured by the manufacturing method CANON KABUSHIKI KAISHA (JP) 2015-10-06 US disclosed
US-9155160-B2 Method of manufacturing organic electroluminescence display device and electronic equipment including organic electroluminescence display device manufactured by the manufacturing method CANON KABUSHIKI KAISHA (JP) 2015-10-06 US disclosed
US-20110042663-A1 DIBENZO[c,g]FLUORENE COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-02-24 US disclosed
US-20110042663-A1 DIBENZO[c,g]FLUORENE COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-02-24 US disclosed
WO-2007069847-A9 NOVEL IMIDAZOQUINAZOLINE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM. LTD. (KR) 2010-12-16 WO disclosed
WO-2010062065-A2 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME 주식회사 엘지화학 (KR) 2010-06-03 WO disclosed
WO-2007069847-A1 NOVEL IMIDAZOQUINAZOLINE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM. LTD. (KR) 2007-06-21 WO disclosed
US-20070131929-A1 Novel imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same LG CHEM. LTD. (KR) 2007-06-14 US disclosed
US-20070131929-A1 Novel imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same LG CHEM. LTD. (KR) 2007-06-14 US disclosed
US-20070108892-A1 Binaphthalene derivatives, preparation method thereof and organic electronic device using the same LG CHEM. LTD. (KR) 2007-05-17 US disclosed
US-20070108892-A1 Binaphthalene derivatives, preparation method thereof and organic electronic device using the same LG CHEM. LTD. (KR) 2007-05-17 US disclosed
WO-2007046658-A1 NEW BINAPHTHALENE DERIVATIVES, PREPARATION METHOD THEREOF AND ORGANIC ELECTRONIC DEVICE USING THE SAME LG CHEM. LTD. (KR) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12024526-B2 Fused polycyclic aromatic compound AHR, PAH, H1-2 CA2 718/4885CA1 2403/4885CA9 2039/4885
US-20230047095-A1 Fused Polycyclic Aromatic Compound AHR, PAH, H1-2 CA2 901/4885CA1 2801/4885CA9 2769/4885
US-20170317295-A1 NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME NPM1, PER2, CRY2 CA2 1889/4885CA1 1513/4885CA9 805/4885
US-20110042663-A1 DIBENZO[c,g]FLUORENE COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE USING THE SAME LEF1, GNG2, SCO2 CA2 3064/4885CA1 2993/4885CA9 1542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.